Table 7.9

Unadjusted Graft Survival, Pancreas After Kidney (PAK) Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

Level of HLA Mismatch 3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 719 87.0% 1.3% 719 77.6% 1.6% 1,328 66.1% 1.5% 1,706 56.7% 1.8%
A Locus Mismatch 0 123 84.6% 3.3% 123 76.2% 3.9% 216 67.5% 3.8% 301 55.7% 4.0%
1 350 86.5% 1.8% 350 78.7% 2.2% 635 66.3% 2.2% 835 58.5% 2.4%
2 246 88.9% 2.0% 246 76.9% 2.7% 477 65.1% 2.6% 570 53.8% 3.6%
B Locus Mismatch 0 54 77.8% 5.7% 54 72.2% 6.1% 102 64.7% 5.5% 141 56.2% 5.7%
1 274 88.7% 1.9% 274 78.8% 2.5% 521 67.6% 2.4% 694 60.2% 2.6%
2 391 87.1% 1.7% 391 77.5% 2.2% 705 65.1% 2.2% 871 53.0% 2.9%
DR Locus Mismatch 0 83 84.3% 4.0% 83 76.7% 4.7% 165 66.3% 4.3% 225 55.0% 4.8%
1 350 88.0% 1.7% 350 78.3% 2.2% 652 65.6% 2.2% 863 57.1% 2.4%
2 285 86.6% 2.0% 285 76.9% 2.5% 509 67.0% 2.5% 616 56.7% 3.3%
Unknown 1 100.0% 0.0% 1 100.0% 0.0% 2 0.0% 0.0% 2 0.0% 0.0%
Total Mismatch 0 19 68.4% 10.7% 19 68.4% 10.7% 28 56.3% 13.4% 35 54.1% 14.4%
1 18 77.8% 9.8% 18 61.1% 11.5% 41 75.4% 6.8% 68 59.2% 7.0%
2 67 88.1% 4.0% 67 81.9% 4.7% 143 63.7% 4.7% 195 52.4% 5.4%
3 146 87.6% 2.7% 146 79.1% 3.4% 255 68.3% 3.4% 353 60.4% 3.4%
4 201 89.5% 2.2% 201 80.2% 2.8% 365 66.2% 3.0% 465 58.2% 3.4%
5 182 86.8% 2.5% 182 75.4% 3.3% 334 64.1% 3.2% 407 53.3% 4.1%
6 85 85.6% 3.9% 85 75.7% 4.7% 160 68.1% 4.1% 181 51.5% 8.5%
Unknown 1 100.0% 0.0% 1 100.0% 0.0% 2 0.0% 0.0% 2 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on pancreas and kidney-pancreas transplants.

Multi-organ transplants are excluded.